Vascular calcification: an update on mechanisms and challenges in treatment

M Wu, C Rementer, CM Giachelli - Calcified tissue international, 2013 - Springer
Vascular calcification is highly associated with cardiovascular disease mortality, particularly
in high-risk patients with diabetes and chronic kidney diseases (CKD). In blood vessels …

Chronic kidney disease: a clinical model of premature aging

P Stenvinkel, TE Larsson - American journal of kidney diseases, 2013 - Elsevier
Premature aging is a process associated with a progressive accumulation of deleterious
changes over time, an impairment of physiologic functions, and an increase in the risk of …

CKD in elderly patients managed without dialysis: survival, symptoms, and quality of life

MA Brown, GK Collett, EA Josland… - Clinical Journal of the …, 2015 - journals.lww.com
Results Nondialysis patients were older than the predialysis group (82 versus 67 years; P<
0.001) but had similar eGFR at the first clinic visit (16 ml/min per 1.73 m 2; P= 0.92). Of the …

[HTML][HTML] Hyperphosphatemia management in patients with chronic kidney disease

AM Shaman, SR Kowalski - Saudi Pharmaceutical Journal, 2016 - Elsevier
Hyperphosphatemia in chronic kidney disease (CKD) patients is a potentially life altering
condition that can lead to cardiovascular calcification, metabolic bone disease (renal …

Vascular calcification and renal bone disorders

KC Lu, CC Wu, JF Yen, WC Liu - The Scientific World Journal, 2014 - Wiley Online Library
At the early stage of chronic kidney disease (CKD), the systemic mineral metabolism and
bone composition start to change. This alteration is known as chronic kidney disease …

[HTML][HTML] Vascular calcification in chronic kidney disease: an update and perspective

SC Ren, N Mao, S Yi, X Ma, JQ Zou, X Tang… - Aging and …, 2022 - ncbi.nlm.nih.gov
Chronic kidney disease is a devastating condition resulting from irreversible loss of nephron
numbers and function and leading to end-stage renal disease and mineral disorders …

Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence

A Covic, A Rastogi - BMC nephrology, 2013 - Springer
In recent years, the imbalance in phosphate homeostasis in patients with end-stage renal
disease (ESRD) has been the subject of much research. It appears that, while …

Lanthanum carbonate: safety data after 10 years

AJ Hutchison, RJ Wilson, S Garafola, JB Copley - Nephrology, 2016 - Wiley Online Library
Despite 10 years of post‐marketing safety monitoring of the phosphate binder lanthanum
carbonate, concerns about aluminium‐like accumulation and toxicity persist. Here, we …

Non-systemic drugs: a critical review

D Charmot - Current pharmaceutical design, 2012 - ingentaconnect.com
Non-systemic drugs act within the intestinal lumen without reaching the systemic circulation.
The first generation included polymeric resins that sequester phosphate ions, potassium …

[HTML][HTML] Small intestinal phosphate absorption: novel therapeutic implications

J Yee, D Rosenbaum, JW Jacobs… - American Journal of …, 2021 - karger.com
Background: Chronic kidney disease (CKD) affects approximately 15% of adults in the USA.
As CKD progresses, urinary phosphate excretion decreases and results in phosphate …